{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:58:08Z","timestamp":1769104688464,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0778-4","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T03:16:21Z","timestamp":1519701381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2219-7142","authenticated-orcid":false,"given":"Joana","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Ana","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Ferreira-Coimbra","sequence":"additional","affiliation":[]},{"given":"Isaac","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o-Tiago","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Louren\u00e7o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"issue":"3","key":"778_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","volume":"2","author":"Y Seta","year":"1996","unstructured":"Seta Y, Shan K, Bozkurt B, et al. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail. 1996;2(3):243\u20139.","journal-title":"J Card Fail"},{"issue":"2","key":"778_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-5273(99)00186-2","volume":"72","author":"R Sharma","year":"2000","unstructured":"Sharma R, Coats AJ, Anker SD. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol. 2000;72(2):175\u201386.","journal-title":"Int J Cardiol"},{"issue":"9","key":"778_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","volume":"100","author":"DL Mann","year":"1999","unstructured":"Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100(9):999\u20131008.","journal-title":"Circulation"},{"issue":"1","key":"778_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.amjcard.2004.08.065","volume":"95","author":"JA Chirinos","year":"2005","unstructured":"Chirinos JA, Zambrano JP, Chakko S, et al. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Am J Cardiol. 2005;95(1):88\u201390.","journal-title":"Am J Cardiol"},{"issue":"1","key":"778_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.CIR.100.1.96","volume":"100","author":"WK Lagrand","year":"1999","unstructured":"Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100(1):96\u2013102.","journal-title":"Circulation"},{"issue":"4","key":"778_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","volume":"28","author":"M Testa","year":"1996","unstructured":"Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28(4):964\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"778_CR7","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","volume":"102","author":"M Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102(25):3060\u20137.","journal-title":"Circulation"},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"3769152","DOI":"10.1155\/2016\/3769152","volume":"2016","author":"U Barbero","year":"2016","unstructured":"Barbero U, D'Ascenzo F, Nijhoff F, et al. Assessing risk in patients with stable coronary disease: when should we intensify care and follow-up? Results from a meta-analysis of observational studies of the COURAGE and FAME era. Scientifica. 2016;2016:3769152.","journal-title":"Scientifica"},{"issue":"5","key":"778_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ahj.2003.11.021","volume":"147","author":"WH Yin","year":"2004","unstructured":"Yin WH, Chen JW, Jen HL, et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J. 2004;147(5):931\u20138.","journal-title":"Am Heart J"},{"key":"778_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijcard.2016.10.038","volume":"226","author":"M Boulogne","year":"2016","unstructured":"Boulogne M, Sadoune M, Launay JM, et al. Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction. Int J Cardiol. 2016;226:53\u20139.","journal-title":"Int J Cardiol"},{"issue":"4","key":"778_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000088138","volume":"104","author":"BS Ronnow","year":"2005","unstructured":"Ronnow BS, Reyna SP, Muhlestein JB, et al. C-reactive protein predicts death in patients with non-ischemic cardiomyopathy. Cardiology. 2005;104(4):196\u2013201.","journal-title":"Cardiology"},{"issue":"11","key":"778_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1046\/j.1365-2362.1996.2560587.x","volume":"26","author":"IC Steele","year":"1996","unstructured":"Steele IC, Nugent AM, Maguire S, et al. Cytokine profile in chronic cardiac failure. Eur J Clin Investig. 1996;26(11):1018\u201322.","journal-title":"Eur J Clin Investig"},{"issue":"6","key":"778_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.healun.2007.01.033","volume":"26","author":"H Tanner","year":"2007","unstructured":"Tanner H, Mohacsi P, Fuller-Bicer GA, et al. Cytokine activation and disease progression in patients with stable moderate chronic heart failure. J Heart Lung Transplant. 2007;26(6):622\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"778_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000006913","volume":"91","author":"K Kaneko","year":"1999","unstructured":"Kaneko K, Kanda T, Yamauchi Y, et al. C-reactive protein in dilated cardiomyopathy. Cardiology. 1999;91(4):215\u20139.","journal-title":"Cardiology"},{"issue":"12","key":"778_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/clc.4960221211","volume":"22","author":"Y Sato","year":"1999","unstructured":"Sato Y, Takatsu Y, Kataoka K, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol. 1999;22(12):811\u20133.","journal-title":"Clin Cardiol"},{"issue":"5","key":"778_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","volume":"5","author":"T Peschel","year":"2003","unstructured":"Peschel T, Schonauer M, Thiele H, et al. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail. 2003;5(5):609\u201314.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"778_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/S0066-782X2007000500014","volume":"88","author":"H Villacorta","year":"2007","unstructured":"Villacorta H, Masetto AC, Mesquita ET. C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq Bras Cardiol. 2007;88(5):585\u20139.","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"778_CR18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1001\/archinte.1988.00380090087021","volume":"148","author":"JK Ghali","year":"1988","unstructured":"Ghali JK, Kadakia S, Cooper R, et al. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med. 1988;148(9):2013\u20136.","journal-title":"Arch Intern Med"},{"issue":"3","key":"778_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0002-9149(96)00294-9","volume":"78","author":"C Opasich","year":"1996","unstructured":"Opasich C, Febo O, Riccardi PG, et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol. 1996;78(3):354\u20137.","journal-title":"Am J Cardiol"},{"issue":"19","key":"778_CR20","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388\u2013442.","journal-title":"Eur Heart J"},{"issue":"3","key":"778_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499\u2013511.","journal-title":"Circulation"},{"issue":"12","key":"778_CR22","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","volume":"115","author":"MS Sabatine","year":"2007","unstructured":"Sabatine MS, Morrow DA, Jablonski KA, et al. Prognostic significance of the centers for disease control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115(12):1528\u201336.","journal-title":"Circulation"},{"issue":"4","key":"778_CR23","first-page":"400","volume":"32","author":"CC Wang","year":"2016","unstructured":"Wang CC, Chang HY, Yin WH, et al. TSOC-HFrEF registry: a registry of hospitalized patients with decompensated systolic heart failure: description of population and management. Acta Cardiologica Sinica. 2016;32(4):400\u201311.","journal-title":"Acta Cardiologica Sinica"},{"issue":"1","key":"778_CR24","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/cc13181","volume":"18","author":"W Wang","year":"2014","unstructured":"Wang W, Zhang X, Ge N, et al. Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases. Crit Care. 2014;18(1):R4.","journal-title":"Crit Care"},{"issue":"3\u20134","key":"778_CR25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3909\/ricm0824","volume":"17","author":"A Mollar","year":"2016","unstructured":"Mollar A, Minana G, Villanueva MP, et al. Utility of Procalcitonin for diagnosis of superimposed infections in patients with acute heart failure. Rev Cardiovasc Med. 2016;17(3\u20134):144\u20138.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"778_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12916-017-0795-7","volume":"15","author":"R Sager","year":"2017","unstructured":"Sager R, Kutz A, Mueller B, et al. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15.","journal-title":"BMC Med"},{"issue":"3","key":"778_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/eurjhf\/hfr177","volume":"14","author":"A Maisel","year":"2012","unstructured":"Maisel A, Neath SX, Landsberg J, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (biomarkers in acute heart failure) trial. Eur J Heart Fail. 2012;14(3):278\u201386.","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"778_CR28","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/eurheartj\/ehl407","volume":"27","author":"K Siirila-Waris","year":"2006","unstructured":"Siirila-Waris K, Lassus J, Melin J, et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J. 2006;27(24):3011\u20137.","journal-title":"Eur Heart J"},{"issue":"4","key":"778_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ahj.2005.06.046","volume":"151","author":"C Mueller","year":"2006","unstructured":"Mueller C, Laule-Kilian K, Christ A, et al. Inflammation and long-term mortality in acute congestive heart failure. Am Heart J. 2006;151(4):845\u201350.","journal-title":"Am Heart J"},{"issue":"5","key":"778_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cardfail.2014.02.002","volume":"20","author":"AP Kalogeropoulos","year":"2014","unstructured":"Kalogeropoulos AP, Tang WH, Hsu A, et al. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail. 2014;20(5):319\u201326.","journal-title":"J Card Fail"},{"issue":"7","key":"778_CR31","first-page":"863","volume":"47","author":"YJ Lee","year":"2009","unstructured":"Lee YJ, Lee JH, Shin YH, et al. Gender difference and determinants of C-reactive protein level in Korean adults. Clin Chem Lab Med. 2009;47(7):863\u20139.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"778_CR32","doi-asserted-by":"publisher","first-page":"e36062","DOI":"10.1371\/journal.pone.0036062","volume":"7","author":"S Ishii","year":"2012","unstructured":"Ishii S, Karlamangla AS, Bote M, et al. Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PLoS One. 2012;7(4):e36062.","journal-title":"PLoS One"},{"issue":"10","key":"778_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011\u201323.","journal-title":"N Engl J Med"},{"issue":"6","key":"778_CR34","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/313792","volume":"30","author":"TT Yoshikawa","year":"2000","unstructured":"Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30(6):931\u20133.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"778_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0736-4679(99)00135-3","volume":"17","author":"B Clyne","year":"1999","unstructured":"Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med. 1999;17(6):1019\u201325.","journal-title":"J Emerg Med"},{"issue":"6","key":"778_CR36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.amjcard.2017.06.020","volume":"120","author":"CM Gijsberts","year":"2017","unstructured":"Gijsberts CM, Ellenbroek G, Ten Berg MJ, et al. Effect of monocyte-to-lymphocyte ratio on heart failure characteristics and hospitalizations in a coronary angiography cohort. Am J Cardiol. 2017;120(6):911\u20136.","journal-title":"Am J Cardiol"},{"issue":"1","key":"778_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2012.04.012","volume":"224","author":"B o Hartaigh","year":"2012","unstructured":"o Hartaigh B, Bosch JA, Thomas GN, et al. Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and cardiovascular health (LURIC) study. Atherosclerosis. 2012;224(1):161\u20139.","journal-title":"Atherosclerosis"},{"issue":"14","key":"778_CR38","doi-asserted-by":"publisher","first-page":"e6558","DOI":"10.1097\/MD.0000000000006558","volume":"96","author":"C Sardu","year":"2017","unstructured":"Sardu C, Santamaria M, Funaro S, et al. Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome. Medicine. 2017;96(14):e6558.","journal-title":"Medicine"},{"issue":"1","key":"778_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-017-0554-2","volume":"16","author":"C Sardu","year":"2017","unstructured":"Sardu C, Barbieri M, Santamaria M, et al. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. Cardiovasc Diabetol. 2017;16(1):75.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"778_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12265-014-9545-9","volume":"7","author":"C Sardu","year":"2014","unstructured":"Sardu C, Marfella R, Santulli G. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res. 2014;7(3):362\u20138.","journal-title":"J Cardiovasc Transl Res"},{"issue":"7","key":"778_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1253\/circj.70.857","volume":"70","author":"C Ishikawa","year":"2006","unstructured":"Ishikawa C, Tsutamoto T, Fujii M, et al. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J. 2006;70(7):857\u201363.","journal-title":"Circ J"},{"issue":"12","key":"778_CR42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.recesp.2016.10.014","volume":"69","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol. 2016;69(12):1167.","journal-title":"Rev Esp Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T22:29:19Z","timestamp":1660516159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0778-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0778-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol conforms to the ethical guidelines of the declaration of Helsinki and it was approved by the local ethics committee \u2013 Comiss\u00e3o de \u00c9tica para a Sa\u00fade do Hospital de S\u00e3o Jo\u00e3o. All patients provided written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"40"}}